Outcomes of Transcatheter or Surgical Treatment of Severe Aortic Stenosis in Patients With Coronary Artery Disease

•Outcomes of surgical aortic valve replacement + coronary artery bypass grafting vs. transcatheter aortic valve replacement (TAVR) + percutaneous coronary intervention (PCI) in severe aortic stenosis and coronary artery disease patients.•TAVR + PCI had lower 30-day acute kidney injury and bleeding, similar 2-year mortality/stroke.•PCI timing (pre-, peri-, and post-TAVR) did not impact long-term clinical outcomes.•Results support TAVR + PCI as a viable option in select high-risk patients.